关注
Michelle Haber
Michelle Haber
Professor and Executive Director, Children's Cancer Institute
在 ccia.unsw.edu.au 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
ABC transporters in cancer: more than just drug efflux pumps
JI Fletcher, M Haber, MJ Henderson, MD Norris
Nature Reviews Cancer 10 (2), 147-156, 2010
12292010
Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.
M Kavallaris, DY Kuo, CA Burkhart, DL Regl, MD Norris, M Haber, ...
The Journal of clinical investigation 100 (5), 1282-1293, 1997
7711997
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
PF Ambros, IM Ambros, GM Brodeur, M Haber, J Khan, A Nakagawara, ...
British journal of cancer 100 (9), 1471-1482, 2009
4592009
ABC transporters as mediators of drug resistance and contributors to cancer cell biology
JI Fletcher, RT Williams, MJ Henderson, MD Norris, M Haber
Drug Resistance Updates 26, 1-9, 2016
4282016
Expression of the gene for multidrug-resistance–associated protein and outcome in patients with neuroblastoma
MD Norris, SB Bordow, GM Marshall, PS Haber, SL Cohn, M Haber
New England Journal of Medicine 334 (4), 231-238, 1996
4161996
Role of the MRP1/ABCC1 multidrug transporter protein in cancer
M Munoz, M Henderson, M Haber, M Norris
IUBMB life 59 (12), 752-757, 2007
2982007
Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells
M Kavallaris, AS Tait, BJ Walsh, L He, SB Horwitz, MD Norris, M Haber
Cancer research 61 (15), 5803-5809, 2001
2862001
Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies
NLM Liem, RA Papa, CG Milross, MA Schmid, M Tajbakhsh, S Choi, ...
Blood 103 (10), 3905-3914, 2004
2582004
ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma
MD Hogarty, MD Norris, K Davis, X Liu, NF Evageliou, CS Hayes, B Pawel, ...
Cancer research 68 (23), 9735-9745, 2008
2512008
miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma
A Swarbrick, SL Woods, A Shaw, A Balakrishnan, Y Phua, A Nguyen, ...
Nature medicine 16 (10), 1134-1140, 2010
2382010
Expression of the Multidrug Resistance-associated Protein (MRP) Gene Correlates with Amplification and Overexpression of the N-myc Oncogene in Childhood …
SB Bordow, M Haber, J Madafiglio, B Cheung, GM Marshall, MD Norris
Cancer research 54 (19), 5036-5040, 1994
2341994
The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics …
RB Lock, N Liem, ML Farnsworth, CG Milross, C Xue, M Tajbakhsh, ...
Blood, The Journal of the American Society of Hematology 99 (11), 4100-4108, 2002
2322002
The histone deacetylase SIRT2 stabilizes Myc oncoproteins
PY Liu, N Xu, A Malyukova, CJ Scarlett, YT Sun, XD Zhang, D Ling, SP Su, ...
Cell Death & Differentiation 20 (3), 503-514, 2013
2272013
Association of High-Level MRP1 Expression With Poor Clinical Outcome in a Large Prospective Study of Primary Neuroblastoma
M Haber, J Smith, SB Bordow, C Flemming, SL Cohn, WB London, ...
Journal of clinical oncology 24 (10), 1546-1553, 2006
2262006
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
M Wong, C Mayoh, LMS Lau, DA Khuong-Quang, M Pinese, A Kumar, ...
Nature medicine 26 (11), 1742-1753, 2020
2222020
Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion
F Voli, E Valli, L Lerra, K Kimpton, F Saletta, FM Giorgi, D Mercatelli, ...
Cancer research 80 (19), 4129-4144, 2020
2072020
The p53 pathway and its inactivation in neuroblastoma
DA Tweddle, ADJ Pearson, M Haber, MD Norris, C Xue, C Flemming, ...
Cancer letters 197 (1-2), 93-98, 2003
1972003
Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification
LM Hansford, WD Thomas, JM Keating, CA Burkhart, AE Peaston, ...
Proceedings of the National Academy of Sciences 101 (34), 12664-12669, 2004
1932004
Altered Expression of Mβ2, the Class II β-Tubulin Isotype, in a Murine J774. 2 Cell Line with a High Level of Taxol Resistance (∗)
M Haber, CA Burkhart, DL Regl, J Madafiglio, MD Norris, SB Horwitz
Journal of Biological Chemistry 270 (52), 31269-31275, 1995
1931995
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
G Schleiermacher, V Mosseri, WB London, JM Maris, GM Brodeur, ...
British journal of cancer 107 (8), 1418-1422, 2012
1912012
系统目前无法执行此操作,请稍后再试。
文章 1–20